...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>癌と化学療法 >Significance of treatment and adequate care in dementia--including point of medical comments in health care insurance system for elderly people by doctors
【24h】

Significance of treatment and adequate care in dementia--including point of medical comments in health care insurance system for elderly people by doctors

机译：治疗的意义和充分护理在痴呆症 - 包括医生老年人医疗保险制度的医疗评论点

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Dementia treatment is one of the most important in home medical care. Donepezil hydrochloride, a dementia treatment drug available in Japan, is a symptomatic therapy but alleviates memory, willingness and feeling disorders and significantly improves QOL. Family doctors will be required to diagnose Alzheimer disease (AD) but it is very difficult for general physician to diagnose AD. This is the reason that the authors devised the simple criteria for diagnosing AD. Meanwhile, recent data from a multi-center study of donepezil hydrochloride for mild cognitive impairment (MCI) conducted in the US suggest that donepezil hydrochloride is also as useful for MCI as for AD. This is considered to suggest the significance to start treatment for AD at the early stage. Care for demented patients is not only the improvement of the apparent dementia. Recent scientific study data may be directly connected to treatment. These days, not a few elderly patients with dementia attend "Day-care Service" and the data indicatethat rehabilitations they have under "Day-care Service" are important and useful. It is considered that non-pharmacological treatment may also play an important role and necessary to accumulate evidences in the future.
机译：痴呆症治疗是家庭医疗保健中最重要的处理之一。 Denpezil盐酸盐，日本可用的痴呆治疗药物，是一种症状性疗法，但减轻了记忆，意愿和感觉障碍，并显着改善了QoL。家庭医生将被要求诊断阿尔茨海默病（广告），但总体医师非常困难诊断广告。这就是作者设计了诊断广告的简单标准的原因。同时，美国在美国进行的温和认知障碍（MCI）的多中心研究中的近期数据表明，盐酸胺盐酸盐也可用作AD的MCI。这被认为是在早期开始治疗广告的重要性。护理患者不仅是表达痴呆的改善。最近的科学研究数据可以直接连接到治疗。这些天，不是一些老年痴呆症患者参加“日间护理服务”，并在“日托服务”下的数据表明康复的数据很重要。据认为，非药理学治疗也可能起到重要作用，并在将来积累证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号